Natixis Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $545K | Sell |
17,424
-6,586
| -27% | -$206K | ﹤0.01% | 1452 |
|
|
2025
Q1 | $806K | Buy |
24,010
+456
| +2% | +$15.3K | ﹤0.01% | 1336 |
|
|
2024
Q4 | $923K | Sell |
23,554
-3,604
| -13% | -$141K | ﹤0.01% | 1322 |
|
|
2024
Q3 | $1.07M | Buy |
27,158
+7,564
| +39% | +$298K | ﹤0.01% | 1278 |
|
|
2024
Q2 | $764K | Sell |
19,594
-82
| -0.4% | -$3.2K | ﹤0.01% | 1329 |
|
|
2024
Q1 | $847K | Sell |
19,676
-1,617
| -8% | -$69.6K | ﹤0.01% | 1267 |
|
|
2023
Q4 | $980K | Sell |
21,293
-731
| -3% | -$33.6K | ﹤0.01% | 1212 |
|
|
2023
Q3 | $752K | Buy |
22,024
+4
| +0% | +$137 | ﹤0.01% | 1246 |
|
|
2023
Q2 | $848K | Buy |
22,020
+279
| +1% | +$10.7K | ﹤0.01% | 1203 |
|
|
2023
Q1 | $778K | Buy |
21,741
+249
| +1% | +$8.91K | ﹤0.01% | 1199 |
|
|
2022
Q4 | $847K | Sell |
21,492
-111
| -0.5% | -$4.38K | ﹤0.01% | 1186 |
|
|
2022
Q3 | $780K | Buy |
21,603
+2,224
| +11% | +$80.3K | ﹤0.01% | 1168 |
|
|
2022
Q2 | $590K | Buy |
+19,379
| New | +$590K | ﹤0.01% | 1243 |
|